Can we predict the future?: Modelling SARS-CoV-2 epidemic to endemic transition
DOI:
https://doi.org/10.47611/jsrhs.v11i3.2898Keywords:
COVID-19, Pandemic, Endemic, Influenza, Hepatitis, Epidemiology ModellingAbstract
COVID-19, an infectious disease caused by the SARS-CoV-2 virus, is the viral agent responsible for the ongoing pandemic. Various vaccines have been developed for different strains of the virus. This has led to reduction in the number of infections and deaths throughout the world, but the pandemic seems to be far from over due to constant mutations in the structure of the virus and other factors like immunity loss rate and re-infections. However, there is guidance to how we should proceed from a public health standpoint, due to the similar cases of influenza and the Hepatitises. These pathogens started out as epidemics or pandemics, then morphed into an endemic over the course of decades. Therefore, by combining our knowledge of these past epidemic to endemic transitions, we have made similar predictions about the transition of the COVID-19 pandemic into endemicity. A simple epidemiological model called the SIR model has been utilized to predict the course of the pandemic by computation, considering 2 cases – one without vaccination intervention and the other with vaccination intervention. The results indicate that COVID-19 is likely already an endemic, but to maintain a stable state and to mitigate the death toll, there is a serious need for continuous vaccination and regular changes in vaccinations as the virus mutates.
Downloads
References or Bibliography
Epidemic and Endemic Influenza. (1962). Canadian Medical Association journal, 86(13), 588–589.
Institute of Medicine (US) Forum on Microbial Threats; Knobler SL, Mack A, Mahmoud A, et al., editors. The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. (2022, May 28) Washington (DC): National Academies Press (US); 2005. 1, The Story of Influenza.
Coburn, B.J., Wagner, B.G. & Blower, S. (2009) Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med 7, 30. https://doi.org/10.1186/1741-7015-7-30
Taubenberger, J. K., & Morens, D. M. (2010). Influenza: the once and future pandemic. Public health reports (Washington, D.C. : 1974), 125 Suppl 3(Suppl 3), 16–26.
Hepatitis B Basics. HHS.gov. (2022, May 28). https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-b-basics/index.html
Franco, E., Bagnato, B., Marino, M. G., Meleleo, C., Serino, L., & Zaratti, L. (2012). Hepatitis B: Epidemiology and prevention in developing countries. World journal of hepatology, 4(3), 74–80. https://doi.org/10.4254/wjh.v4.i3.74
COVID Data Tracker. (2022, May 28). Centers for Disease Control (CDC). https://covid.cdc.gov/covid-data-tracker/#datatracker-home
Sen, D., & Sen, D. (2021). Use of a Modified SIRD Model to Analyze COVID-19 Data. Industrial & Engineering Chemistry Research, acs.iecr.0c04754. https://doi.org/10.1021/acs.iecr.0c04754
Nicholson L. B. (2016). The immune system. Essays in biochemistry, 60(3), 275–301. https://doi.org/10.1042/EBC20160017
Hepatitis B Endemic Countries List. (2022, May 28) Alberta Doctors. https://albertadoctors.org
Zada, I., Naeem Jan, M., Ali, N. et al. (2021) Mathematical analysis of hepatitis B epidemic model with optimal control. Adv Differ Equ 2021, 451. https://doi.org/10.1186/s13662-021-03607-2
Hou, J., Liu, Z., & Gu, F. (2005). Epidemiology and Prevention of Hepatitis B Virus Infection. International journal of medical sciences, 2(1), 50–57. https://doi.org/10.7150/ijms.2.50
Yewdell J. W. (2021). Antigenic drift: Understanding COVID-19. Immunity, 54(12), 2681–2687. https://doi.org/10.1016/j.immuni.2021.11.016
Watford S, Warrington SJ. Bacterial DNA Mutations. [Updated 2022 Apr 14]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
Forbi JC, Vaughan G, Purdy MA, Campo DS, Xia GL, Ganova-Raeva LM, Ramachandran S, Thai H, Khudyakov YE. (2010) Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS One. 5(7):e11615. doi: 10.1371/journal.pone.0011615. PMID: 20657838; PMCID: PMC2906510.
Oran, D. P., & Topol, E. J. (2021). The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review. Annals of internal medicine, 174(5), 655–662. https://doi.org/10.7326/M20-6976
Rahman A, Kuddus MA. Modelling the Transmission Dynamics of COVID-19 in Six High-Burden Countries. Biomed Res Int. 2021 May 27;2021:5089184. doi: 10.1155/2021/5089184. PMID: 34124240; PMCID: PMC8172286.
Ma, X., Zhou, Y., & Cao, H. (2013). Global stability of the endemic equilibrium of a discrete SIR epidemic model. Advances in difference equations, 2013(1), 42. https://doi.org/10.1186/1687-1847-2013-42
Published
How to Cite
Issue
Section
Copyright (c) 2022 Krish Agrawal; Ari
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.